Anti-alpha Adducin (phospho S436) antibody [EPR2176]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal alpha Adducin phospho S436 antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
ADDA, ADD1, Alpha-adducin, Erythrocyte adducin subunit alpha
- WB
Lab
Western blot - Anti-alpha Adducin (phospho S436) antibody [EPR2176] (AB125081)
Blocking and diluting buffer and concentration : 5% NFDM/TBST. ab181602 was used as a GAPDH loading control.
All lanes:
Western blot - Anti-alpha Adducin (phospho S436) antibody [EPR2176] (ab125081) at 1/1000 dilution
Lane 1:
Untreated HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HeLa (Human cervix adenocarcinoma epithelial cell) treated with 50nM Calyculin A for 3 hours whole cell lysate at 20 µg
Lane 3:
HeLa (Human cervix adenocarcinoma epithelial cell) treated with 50nM Calyculin A for 3 hours whole cell lysate 20ug, then the membrane was treated with alkaline phosphatase for 1 hour
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 81 kDa
Observed band size: 110 kDa
false
Exposure time: 7s
- WB
Unknown
Western blot - Anti-alpha Adducin (phospho S436) antibody [EPR2176] (AB125081)
The bands shown at the bottom of the gel are Beta Tubulin.
All lanes:
Western blot - Anti-alpha Adducin (phospho S436) antibody [EPR2176] (ab125081) at 1/1000 dilution
Lane 1:
HeLa cell lysate, untreated at 10 µg
Lane 2:
HeLa cell lysate, treated with Lambda Phosphatase at 10 µg
Secondary
All lanes:
Goat anti-Rabbit HRP at 1/2000 dilution
Predicted band size: 81 kDa,86 kDa
Observed band size: 90 kDa
false
Related conjugates and formulations (1)
-
Anti-alpha Adducin (phospho S436) antibody [EPR2176] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein influences cellular shape and motility. It forms a complex with spectrin and actin to strengthen cell membranes and facilitate intercellular connectivity. Alpha Adducin modulates the dynamics of membrane skeleton structures impacting not only the stability but also the function of cells under both physiological and pathophysiological conditions.
Pathways
Alpha Adducin is integral in the regulation of the Rho and calcium signaling pathways. These pathways influence cytoskeletal organization and cell life processes. In the Rho pathway alpha Adducin interacts with proteins such as Rho GTPases which are involved in signal transduction for cytoskeletal rearrangement. This interaction shows its importance in cellular reaction to environmental stimuli and stress.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
PloS one 13:e0197266 PubMed29768513
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com